Voyager Therapeutics (VYGR) Profit After Tax (2014 - 2026)

Voyager Therapeutics (VYGR) has 13 years of Profit After Tax data on file, last reported at -$295000.0 in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 241.83% year-over-year to -$295000.0; the trailing twelve-month figure through Mar 2026 stood at -$60.4 million (down 220.41% YoY), and the FY2025 full-year result was -$119.3 million, down 33126.18% from the prior year.
• Profit After Tax rose to -$295000.0 in Q1 2026, from -$27.0 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $132.5 million in Q4 2023 to a low of -$33.4 million in Q2 2025.
• A 5-year average of $4.2 million and a median of -$10.1 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax soared 681.85% in 2023 and slumped 7115.78% in 2025, its largest moves.
• Tracing VYGR's Profit After Tax over 5 years: stood at -$23.7 million in 2022, then surged by 659.03% to $132.5 million in 2023, then slumped by 100.28% to -$374000.0 in 2024, then tumbled by 7115.78% to -$27.0 million in 2025, then surged by 98.91% to -$295000.0 in 2026.
• Business Quant data shows VYGR's Profit After Tax at -$295000.0 in Q1 2026, -$27.0 million in Q4 2025, and $228000.0 in Q3 2025.